M. Najah

发表

Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia.

P. Tarugi, M. Najah, E. Di Leo, 2009, Clinica chimica acta; international journal of clinical chemistry.

Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia.

P. Tarugi, S. Calandra, M. Najah, 2013, Gene.

A novel splice site mutation of the LDL receptor gene in a Tunisian hypercholesterolemic family.

C. Boileau, S. Lestavel, M. Varret, 2008, Clinica chimica acta; international journal of clinical chemistry.

Molecular characterization of Tunisian families with abetalipoproteinemia and identification of a novel mutation in MTTP gene

A. Sassolas, M. Najah, Jelassi Awatef, 2013, Diagnostic Pathology.

Limited mutational heterogeneity in the LDLR gene in familial hypercholesterolemia in Tunisia.

C. Boileau, M. Varret, J. Rabès, 2009, Atherosclerosis.

Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.

M. Varret, M. Najah, M. Slimane, 2010, Clinica chimica acta; international journal of clinical chemistry.

Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease.

M. Najah, M. Slimane, M. Rouis, 2007, The American journal of cardiology.

Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease

M. Najah, M. Slimane, M. Rouis, 2011, Coronary artery disease.

Genomic characterization of two deletions in the LDLR gene in Tunisian patients with familial hypercholesterolemia.

C. Boileau, M. Abifadel, M. Varret, 2012, Clinica chimica acta; international journal of clinical chemistry.

Effect of Genetic Polymorphism +294T/C in Peroxisome Proliferator-Activated Receptor Delta on the Risk of Ischemic Stroke in a Tunisian Population

M. Najah, M. Slimane, M. Rouis, 2013, Journal of Molecular Neuroscience.

PCSK9 polymorphism in a Tunisian cohort: identification of a new allele, L8, and association of allele L10 with reduced coronary heart disease risk.

C. Boileau, W. Jomaa, M. Abifadel, 2015, Molecular and cellular probes.

+294T/C polymorphism in the PPAR-delta gene is associated with risk of coronary artery disease in normolipidemic Tunisians.

M. Najah, M. Slimane, M. Rouis, 2010, Genetics and molecular research : GMR.

Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population

M. Varret, M. Najah, M. Slimane, 2013, Current genomics.

Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.

C. Boileau, M. Abifadel, M. Varret, 2012, Atherosclerosis.

+ 294 T / C polymorphism in the PPAR-δ gene is associated with risk of coronary artery disease in normolipidemic

M. Najah, M. Slimane, M. Rouis, 2010 .

Effect of Genetic Polymorphism +294T/C in Peroxisome Proliferator-Activated Receptor Delta on the Risk of Ischemic Stroke in a Tunisian Population

M. Najah, M. Slimane, M. Rouis, 2013, Journal of Molecular Neuroscience.

Effect of a splice site mutation in LDLR gene and two variations in PCSK9 gene in Tunisian families with familial hypercholesterolaemia

M. Varret, M. Najah, M. Slimane, 2011, Annals of clinical biochemistry.